AN2 Therapeutics, Inc.

Menlo Park, CA

UEI
DD4FE2GE4L78
CAGE
822Z2
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1800 El Camino Real UNIT D, Menlo Park, CA 94025, USA
Founded
2019
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $456,766
FY2024 $3,821,365
FY2023 $651,041

Contract awards

Quick answers

Is AN2 Therapeutics, Inc. registered in SAM.gov?

AN2 Therapeutics, Inc.'s SAM.gov registration expired on June 24, 2026.

What is AN2 Therapeutics, Inc.'s CAGE code?

AN2 Therapeutics, Inc.'s CAGE code is 822Z2, and its Unique Entity ID (UEI) is DD4FE2GE4L78.

How much has AN2 Therapeutics, Inc. received in federal contracts?

Federal contracts obligated $456,766 to AN2 Therapeutics, Inc. in fiscal year 2025 and $4,929,172 in fiscal years 2023 through 2027.

What is AN2 Therapeutics, Inc.'s most recent federal award?

AN2 Therapeutics, Inc.'s most recent federal contract award is Development of epetraborole as a novel therapeutic for melioidosis and additional antimicrobial resistant (AMR)… (75N93022C00059), from National Institute of Allergy and Infectious Diseases (NIH), on September 20, 2022.

On GovTribe

See AN2 Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe